Julia Rohe-Schiffner
Berlin, BE 10117, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 17 publications
Cost-effectiveness of RSVpreF for the prevention of respiratory syncytial virus illness among high-risk adults in Germany.
Journal: Expert review of vaccines
Published: July 31, 2026
Long-term sequelae after tick-borne encephalitis in Germany: a nationwide claims-based matched cohort study.
Journal: Ticks and tick-borne diseases
Published: April 08, 2026
Cost-Effectiveness of Alternative Immunization Strategies to Protect Infants Against Respiratory Syncytial Virus in Germany: A Decision Modeling Study.
Journal: Infectious diseases and therapy
Published: December 03, 2025
Evaluating the impact of population-based and cohort-based models in cost-effectiveness analysis: a case study of pneumococcal conjugate vaccines in infants in Germany.
Journal: Journal of medical economics
Published: July 21, 2025
Impact of Revised Vaccination Recommendations for Mature Infants on Premature Infants' Vaccination Compliance in Germany.
Journal: Infectious diseases and therapy
Published: October 07, 2024
Economic burden of respiratory syncytial virus in adults in Germany - a health claims analysis between 2015 and 2018.
Journal: Journal of medical economics
Published: August 06, 2024
Pneumococcal vaccination rates in immunocompromised patients in Germany: A retrospective cohort study to assess sequential vaccination rates and changes over time.
Journal: PloS one
Published: August 26, 2021
Vaccination rate and adherence of tick-borne encephalitis vaccination in Germany.
Journal: Vaccine
Published: October 16, 2020
Population-based incidence and mortality of community-acquired pneumonia in Germany.
Journal: PloS one
Published: July 24, 2020
Pneumococcal vaccination rates in immunocompromised patients-A cohort study based on claims data from more than 200,000 patients in Germany.
Journal: PloS one
Published: March 20, 2019
Last Updated: 09/26/2026